DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

B of A Securities Downgrades Alexion Pharmaceuticals to Neutral, Lowers Price Target to $110

B of A Securities downgrades Alexion Pharmaceuticals (NASDAQ:ALXN) from Buy to Neutral and lowers the price target from $130 to $110.

Benzinga · 03/05/2020 11:26

B of A Securities downgrades Alexion Pharmaceuticals (NASDAQ:ALXN) from Buy to Neutral and lowers the price target from $130 to $110.